Patients with moderate-to-severe active Sjögren’s disease who received nipocalimab showed improvements in disease activity.
The following is a summary of “Efficacy and safety of intranasal medications for allergic rhinitis: Network meta-analysis,” published in the November 2024 issue of Allergy and Immunology by Sousa-Pinto et al. Intranasal antihistamines (INAH), corticosteroids...
The following is a summary of “Hypoxia-reduced YAP phosphorylation enhances expression of Mucin5AC in nasal epithelial cells of chronic rhinosinusitis with nasal polyps,” published in the November 2024 issue of Allergy and Immunology by Zhong et al. Chronic...
The following is a summary of “Effect of Mepolizumab in airway’s remodelling in patients with late-onset severe asthma with an eosinophilic phenotype,” published in the November 2024 issue of Allergy and Immunology by Domvri et al. Clinical trials show mepolizumab...
The following is a summary of “Phase 2b randomized clinical trial of amlitelimab, an anti-OX40 ligand antibody, in patients with moderate-to-severe atopic dermatitis,” published in the November 2024 issue of Allergy and Immunology by Weidinger et al. Amlitelimab...
Patients with moderate-to-severe active Sjögren’s disease who received nipocalimab showed improvements in disease activity.
The following is a summary of “Efficacy and safety of intranasal medications for allergic rhinitis: Network meta-analysis,” published in the November 2024 issue of Allergy and Immunology by Sousa-Pinto et al. Intranasal antihistamines (INAH), corticosteroids...
The following is a summary of “Hypoxia-reduced YAP phosphorylation enhances expression of Mucin5AC in nasal epithelial cells of chronic rhinosinusitis with nasal polyps,” published in the November 2024 issue of Allergy and Immunology by Zhong et al. Chronic...
The following is a summary of “Effect of Mepolizumab in airway’s remodelling in patients with late-onset severe asthma with an eosinophilic phenotype,” published in the November 2024 issue of Allergy and Immunology by Domvri et al. Clinical trials show mepolizumab...
The following is a summary of “Phase 2b randomized clinical trial of amlitelimab, an anti-OX40 ligand antibody, in patients with moderate-to-severe atopic dermatitis,” published in the November 2024 issue of Allergy and Immunology by Weidinger et al. Amlitelimab...
In this medical fiction tale, an ED physician at a women’s clinic defends her sanctuary from violent men, using her ED skills and frozen turkey legs to survive.
Identity theft in the medical office setting encompasses two serious issues: fraudulent use of a patient’s coverage information and breaching medical records.
Winter affects sleep schedules through daylight shifts, reduced sunlight, and seasonal illness, negatively impacting sleep quality and overall health.
This course discusses how preexisting chronic rhinosinusitis (CRS) is potentially causally linked with new onset asthma over time.
Medical cartoon by Van Scott in which patient asks doctor to pinkie swear that his medical information will remain private.
Identity theft in the medical office setting encompasses two serious issues: fraudulent use of a patient’s coverage information and breaching medical records.
Healthcare organizations often fail to acknowledge the role that interoperability, payer denials, and medical billing play in ensuring payment to physicians.
The standard of care definition can vary during medical malpractice cases, and physicians must prove they acted in accordance with good, accepted practice.
Insights from the leaders in medical research, trending topics in clinical medicine, and perspectives from your colleagues.
Subscribe to our free Newsletters to receive weekly emails, and even get a laugh or two from our medical cartoons.
